Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive acute lymphoblastic leukemia.
Guan-Hua HuXiao-Hui ZhangKai-Yan LiuLan-Ping XuYu WangYi-Fei ChengXiao-Jun HuangPublished in: Acta haematologica (2024)
patients with R/R ETV6/RUNX1-positive ALL may benefit from haplo-HSCT. Deeply eliminating pre-HSCT MRD and preemptive treatment for post-HSCT MRD may be crucial to further improving the prognosis.
Keyphrases
- acute lymphoblastic leukemia
- allogeneic hematopoietic stem cell transplantation
- prognostic factors
- hematopoietic stem cell
- bone marrow
- acute myeloid leukemia
- stem cell transplantation
- peripheral blood
- low dose
- combination therapy
- young adults
- cord blood
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma